Orthodontic practices are valued on EBITDA multiples that reflect case start volume, average case fees, treatment mix, associate provider coverage, pending revenue, and multi-location growth potential. EBITDA, or earnings before interest, taxes, depreciation, and amortization, measures the practice's annual operating profit from providing orthodontic treatment services. The 4x to 8x EBITDA range spans solo-provider practices with modest case volume at the low end and multi-provider operations with strong case starts, modern treatment capabilities, and proven associate models at the top.

Adjusted EBITDA for an orthodontic practice normalizes owner-orthodontist compensation to fair market value. A practice generating $2.8M annual collections with 45% in clinical and staff labor, 12% in facility costs, 8% in lab and supplies, and 10% in administrative overhead produces roughly $700K EBITDA at a 25% margin. Adjusting owner compensation to market rate for an employed orthodontist at $350K-400K brings adjusted EBITDA to $750K-$850K. At 6x EBITDA the practice values at $4.5M-$5.1M. A comparable practice with 40 monthly case starts, associate coverage, and $6,800 average fees might command 7.5x, or $5.6M-$6.4M — case volume and provider coverage create a $1.1M-$1.3M valuation difference.

Monthly new case starts are the foundational growth metric. Practices consistently starting 30-plus new cases monthly demonstrate market demand and referral network strength. Case start trends over 12-24 months reveal trajectory: growing starts signal expanding market share while declining patterns indicate competitive pressure from direct-to-consumer aligners, discount providers, or general dentists offering orthodontic services. Buyers model case starts against average treatment duration of 18-24 months to project active patient counts and the revenue pipeline supporting forward EBITDA. Conversion rates from consultation to case acceptance above 70% indicate effective case presentation, treatment coordinator performance, and financial arrangement flexibility. Practices in growing suburban markets with demographics favoring the 8-18 age bracket show the strongest case start trajectories and growth runway.

Average case fee determines revenue per patient and collection trajectory. Practices averaging $6,500-plus per case generate substantially more revenue per chair hour than competitors at $4,500-5,000. Fee levels reflect market positioning, case complexity mix, and financial coordination sophistication. Comprehensive payment programs including in-house financing, third-party options through OrthoBanc or CareCredit, and insurance maximization capture cases that price-resistant competitors lose. Geographic market influences fee ceilings: affluent suburban practices support premium pricing while urban competitive markets face compression. Direct-to-consumer aligner companies offering treatment at $2,000-3,500 create price pressure at the lower end of the market, making comprehensive treatment capability and fee discipline important valuation factors.

Treatment mix between traditional braces and clear aligners indicates practice modernization and patient demographic breadth. Practices generating 35-plus percent of revenue from clear aligner cases demonstrate technology adoption appealing to the growing adult orthodontic market. Clear aligner cases at $5,500-7,500 typically require fewer in-office visits than braces, improving provider productivity per case. Comprehensive braces cases for complex malocclusions command higher total fees and demonstrate clinical expertise that limits competition. Emerging technologies including accelerated treatment systems and digital treatment planning with 3D printing create efficiency advantages. Balanced portfolios serving both adult aligner patients and adolescent braces patients provide the broadest market coverage and revenue diversification.

Associate provider coverage determines practice transferability and directly impacts applicable EBITDA multiples. Practices where associates deliver 50-plus percent of clinical care demonstrate that patients accept treatment from providers other than the owner, enabling post-acquisition transitions without significant patient attrition. Associates with two-plus years tenure and established patient relationships provide continuity. Solo practices where the owner delivers all treatment face 20-35% valuation discounts because buyers must either deliver all clinical care personally or recruit replacement providers, which takes 6-12 months and risks patient loss during transition. DSO buyers specifically target practices with proven associate models because their platform requires employed-provider clinical delivery at scale.

Pending revenue from active cases represents contracted future collections providing immediate post-acquisition cash flow. A practice with 400 active patients at $2,500 average remaining balance holds $1M in pending revenue converting to collections over 12-24 months. This revenue bridge sustains cash flow during transition periods when new case starts may temporarily decline. Collection rates above 95% on pending balances indicate strong financial coordination. Buyers may value pending revenue separately from practice EBITDA or incorporate it into the overall multiple analysis depending on deal structure.

The buyer landscape includes orthodontic-focused DSOs like Smile Doctors and OrthoSynetics paying 6x-8x EBITDA for multi-provider practices with strong case starts, general dental DSOs like Heartland and Aspen adding orthodontic capabilities at 5x-7x, PE firms entering specialty dental consolidation at 5x-7x, and individual orthodontists purchasing practices at 4x-5x. DSO platforms pay top multiples for practices that serve as regional hubs supporting satellite office expansion and demonstrate proven associate clinical models.